Haemato AG - ESG Rating & Company Profile powered by AI
The page is a zero-cost ESG report for Haemato AG. Full Sustainability assessment of Haemato AG are accessed by logging in. This dashboard contains a questions and answers section for Haemato AG.
Haemato AG in the Real Estate Rental, Development & Operations industry gained a UN SDG ESG Transparency Score of 2.0; made up of an environmental score of 2.0, social score of 2.0 and governance score of 2.0.
2.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | GLP Pte Ltd | 8.0 | High |
1 | CBRE Services Inc | 8.0 | High |
... | ... | ... | |
848 | Sun Hung Kai Properties Ltd | 2.1 | Medium |
848 | Seazen Holdings Co Ltd | 2.1 | Medium |
851 | Haemato AG | 2.0 | Medium |
851 | Ajial Real Estate Entertainment Co KSCP | 2.0 | Medium |
851 | IFM Immobilien AG | 2.0 | Medium |
... | ... | ... | |
1122 | ZongTai Real Estate Development Co Ltd | 0.0 | Low |
1122 | e-Starco Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Haemato AG have an accelerator or VC vehicle to help deliver innovation?
Does Haemato AG disclose current and historical energy intensity?
Does Haemato AG report the average age of the workforce?
Does Haemato AG reference operational or capital allocation in relation to climate change?
Does Haemato AG disclose its ethnicity pay gap?
Does Haemato AG disclose cybersecurity risks?
Does Haemato AG offer flexible work?
Does Haemato AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Haemato AG disclose the number of employees in R&D functions?
Does Haemato AG conduct supply chain audits?
Does Haemato AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Haemato AG conduct 360 degree staff reviews?
Does Haemato AG disclose the individual responsible for D&I?
Does Haemato AG disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Haemato AG disclose current and / or historical scope 2 emissions?
Does Haemato AG disclose water use targets?
Does Haemato AG have careers partnerships with academic institutions?
Did Haemato AG have a product recall in the last two years?
Does Haemato AG disclose incidents of discrimination?
Does Haemato AG allow for Work Councils/Collective Agreements to be formed?
Has Haemato AG issued a profit warning in the past 24 months?
Does Haemato AG disclose parental leave metrics?
Does Haemato AG disclose climate scenario or pathway analysis?
Does Haemato AG disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Haemato AG disclose the pay ratio of women to men?
Does Haemato AG support suppliers with sustainability related research and development?
Does Haemato AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Haemato AG reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Haemato AG involved in embryonic stem cell research?
Does Haemato AG disclose GHG and Air Emissions intensity?
Does Haemato AG disclose its waste policy?
Does Haemato AG report according to TCFD requirements?
Does Haemato AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Haemato AG disclose energy use targets?
Does Haemato AG disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Haemato AG have a policy relating to cyber security?
Have a different question?
Potential Risks for Haemato AG
These potential risks are based on the size, segment and geographies of the company.
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.